NCT03071523

Brief Summary

Different augmentation techniques has been proposed to resolve problem of hard and/or soft tissue ridge defects to enable dental implant placement. Guided bone regeneration GBR procedure is considered as an acceptable reliable surgical procedure for localized ridge augmentation. Exposure of the membrane used for the GBR is considered a major disadvantage of this procedure. In order to avoid such complication, various flap advancement techniques have been proposed such as Periosteal releasing incision,Double-Flap Incision,Coronally advanced lingual flap. The study compare between the flap advancement provided by Periosteal releasing incision,versus,Coronally advanced lingual flap in the treatment of class 1 ridge defect.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 13, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 7, 2017

Completed
1.8 years until next milestone

Study Start

First participant enrolled

December 20, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2019

Completed
Last Updated

July 29, 2021

Status Verified

July 1, 2021

Enrollment Period

11 months

First QC Date

January 13, 2017

Last Update Submit

July 26, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Flap advancement

    Using periodontal probe in millimeters.

    Intra-operative after flap release by either periosteal releasing incision or lingual flap advancment

Secondary Outcomes (4)

  • Bone width gain

    9 month

  • Postoperative membrane exposure

    9 month

  • Postoperative Pain

    2 weeks

  • Postoperative swelling

    2 weeks

Study Arms (2)

coronally advanced lingual flap

EXPERIMENTAL

Full-thickness crestal incision will be made over the edentulous ridge followed by one full-thickness vertical incision on the buccal side. On the buccal side, full thickness mucoperiosteal flap will be raised with horizontal incision 1-3 mm in depth performed in the buccal flap. On the lingual side, a full-thickness mucoperiosteal flap will be elevated until reaching the mylohyoid line. A band of mylohyoid muscle is inserted into the inner part of the lingual flap approximately 5 mm from the crest in an apical direction. A blunt instrument will be inserted below that connective band, and, with gentle traction in the coronal direction, this muscular insertion should be detached freeing the lingual flap from the mylohyoid.

Procedure: coronally advanced lingual flap

periosteal releasing incision technique

ACTIVE COMPARATOR

Full-thickness crestal incision will be made over the edentulous ridge followed by one full-thickness vertical incision on the buccal side and a full thickness flap will be raised. Xenograft and Ti-mesh will be used to augment the defective site then incremental incisions of 1-3 mm into the periosteum and submucosa will be used to advance the muco-periosteal flap. The flap will then be sutured with interrupted sutures.

Procedure: periosteal releasing incision

Interventions

Full-thickness crestal incision will be made over the edentulous ridge followed by one full-thickness vertical incision on the buccal side. On the buccal side, full thickness mucoperiosteal flap will be raised with horizontal incision 1-3 mm in depth performed in the buccal flap. On the lingual side, a full-thickness mucoperiosteal flap will be elevated until reaching the mylohyoid line. A band of mylohyoid muscle is inserted into the inner part of the lingual flap approximately 5 mm from the crest in an apical direction. A blunt instrument will be inserted below that connective band, and, with gentle traction in the coronal direction, this muscular insertion should be detached freeing the lingual flap from the mylohyoid.

coronally advanced lingual flap

Full-thickness crestal incision will be made over the edentulous ridge followed by one full-thickness vertical incision on the buccal side and a full thickness flap will be raised. Xenograft and Ti-mesh will be used to augment the defective site then incremental incisions of 1-3 mm into the periosteum and submucosa will be used to advance the muco-periosteal flap. The flap will then be sutured with interrupted sutures.

periosteal releasing incision technique

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Partially edentulous patients in the mandibular posterior region.
  • Patients with healthy systemic conditions.
  • Insufficient ridge width (\< 5mm).
  • Presence of proper inter-arch space for placement of the implant prosthetic part with adequate soft tissue biotype (≥ 2mm).
  • No clinical evidence of active periodontal disease or oral infections.

You may not qualify if:

  • Patients with systemic conditions that may interfere with the results of the study.
  • Patients with local pathological defects related to the area of interest.
  • Unmotivated, uncooperative patients with poor oral hygiene.
  • Patients with habits that may jeopardize the implant longevity and affect the results of the study such as smoking, alcoholism or para-functional habits.
  • History of bone associated diseases or medication affecting bone metabolism e.g. bisphosphonate treatment.
  • History of radiation therapy in the head or neck region.
  • Current antitumor chemotherapy.
  • Pregnancy.
  • Inflammatory and autoimmune diseases of the oral cavity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rasha Attia

Cairo, Cairo Governorate, 11563, Egypt

Location

Study Officials

  • Manal M. Hosny, Professor

    Cairo University

    STUDY CHAIR
  • Hany E. El-Nahas, Assist. Prof

    Cairo University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

January 13, 2017

First Posted

March 7, 2017

Study Start

December 20, 2018

Primary Completion

November 20, 2019

Study Completion

December 20, 2019

Last Updated

July 29, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations